A Study to Evaluate Sigma-1 and Dopamine-2 Receptor Occupancy by Pridopidine in the Human Brain of Healthy Volunteers and in Patients With Huntington's Disease
Clinical trial NCT03019289 · COMPLETED
Trial details
- NCT number
- NCT03019289
- Sponsor
- Prilenia
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-19
- Primary completion
- 2018-02-09
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.